Product ID: SQMIG35I2154
Report ID:
SQMIG35I2154 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
59 |
Figures:
75
North America dominated the global meningococcal vaccines market. The region's dominance can be attributed to several factors, including well-established healthcare infrastructure, high healthcare expenditure, and strong government initiatives for disease prevention and immunization. Additionally, the presence of major pharmaceutical companies and research institutions focused on vaccine development contributes to the growth of the market in this region. Furthermore, increasing awareness among the population about the importance of vaccination and the rising prevalence of meningitis are driving the demand for meningococcal vaccines in North America.
On the other hand, the Asia-Pacific (APAC) region is experiencing significant growth in the meningococcal vaccines market. Factors such as a large population base, growing healthcare expenditure, and increasing awareness about meningococcal diseases are contributing to the market growth in APAC. Countries like India and China have witnessed a rise in the incidence of meningitis, leading to an increased demand for vaccines. Additionally, the expansion of immunization programs and government initiatives to control the spread of meningococcal diseases are further driving the market growth in the APAC region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35I2154